Mohammed Abdul-Latif

Assessment of Malaria Burden and Community Response to Control and Management Programs

Fahmida Khatoon, Naglaa M. Shalaby, Aida El Alginawi, Z. Kara et autres

INTRODUCTION: Malaria continues to be a significant public health issue, particularly in tropical and subtropical regions. Despite extensive efforts to reduce its burden through various control programs, malaria remains a major cause of morbidity and mortality. This study aims to assess the …

us, sa, Égypte, gb (code pays fourni par la source)

3528 Identifying regions at risk of treatment failure and residual disease in cervical cancer chemoradiotherapy: An adapted risk-score

Mohammed Abdul-Latif, Amani Chowdhury, Hannah Tharmalingam, Y. Tsang et autres

3474 Spatial and temporal changes in functional magnetic resonance imaging parameters in cervical cancer chemoradiotherapy

Mohammed Abdul-Latif, Amani Chowdhury, Hannah Tharmalingam, Peter Hoskin et autres

3743 Predictors of outcome for focal HDR salvage prostate brachytherapy in locally relapsed prostate cancer

Amani A. Chowdhury, Roberto Alonzi, Peter Ostler, Milan Anjanappa et autres

Does radiation-induced lymphocytopenia matter? Developing a radiotherapy dosimetric strategy for immune preservation and improved survival

Mohammed Abdul-Latif, John Conibear, Niluja Thiruthaneeswaran, Y. Tsang

Globally, around half of all patients with cancer require radiotherapy as a part of their multimodality cancer treatment.1 Despite its important role in optimising cancer outcomes, its systemic immunological consequences, particularly radiation-induced lymphocytopenia, can pose a significant challenge and be associated with …

gb, au, ca (code pays fourni par la source)

Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer

Gianmarco Leone, Francesco Orlando, Peter Dutey‐Magni, Osvaldas Vainauskas et autres

This randomized clinical trial explores whether hormone intensification at start of androgen deprivation therapy alters selection of androgen receptor (AR) gene alterations within the gene body and/or enhancer region.

gb, it (code pays fourni par la source)

EV376/#556 Factors contributing to venous thromboembolism in patients undergoing brachytherapy for gynaecological cancers

N. Gupta, Hannah Tharmalingam, Peter Hoskin, Mohammed Abdul-Latif

280: Salvage brachytherapy in second ipsilateral breast tumor event: Relating dosimetry with late toxicity

Mohammed Abdul-Latif, Jocelyn Gal, Renaud Schiappa, Mathieu Gautier et autres

560: Outcomes of stereotactic body radiotherapy on oligometastatic and oligoprogressive breast cancer

S. Armstrong, Andreas Makris, Katherine Belessiotis-Richards, Mohammed Abdul-Latif et autres

1045: Characterising spatial distribution of imaging parameters in cervical cancer

Mohammed Abdul-Latif, Amani Chowdhury, Hannah Tharmalingam, Y. Tsang et autres

1012: Temporal changes in functional magnetic resonance imaging for cervix cancer during chemoradiotherapy

Mohammed Abdul-Latif, Amani Chowdhury, Hannah Tharmalingam, Y. Tsang et autres

1127: Analysis of interstitial catheter number and dosimetric parameters in cervical cancer brachytherapy

Amani A. Chowdhury, Gerry Lowe, Mohammed Abdul-Latif, Hannah Tharmalingam et autres